Atıf İçin Kopyala
Oztop I., Alacacioglu A., ÜNEK İ. T., Tarhan O., Somali I., Cokmert S., ...Daha Fazla
JOURNAL OF BUON, cilt.15, sa.3, ss.462-469, 2010 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
15
Sayı:
3
-
Basım Tarihi:
2010
-
Dergi Adı:
JOURNAL OF BUON
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.462-469
-
Anahtar Kelimeler:
advanced stage, 5-fluorouracil, gemcitabine, pancreatic cancer, PHASE-III TRIAL, COOPERATIVE-ONCOLOGY-GROUP, ORAL FLUOROPYRIMIDINE CARBAMATE, METASTATIC COLORECTAL-CANCER, 1ST-LINE TREATMENT, RANDOMIZED-TRIAL, ADVANCED-CARCINOMA, ITALIAN GROUP, FOLINIC ACID, FLUOROURACIL
-
Dokuz Eylül Üniversitesi Adresli:
Evet
Özet
Purpose: Advanced pancreatic cancer (APC) has a poor prognosis and chemotherapy remains the primary treatment modality. Gemcitabine (GEM) and 5-fluorouracil (5-FU) are the most active drugs in the treatment of pancreatic cancer This study evaluated the efficacy and tolerability of the combination of these agents in APC.